Skip to main content

Table 1 Baseline characteristics and clinical demographics of the study population

From: Progression of coronary atherosclerotic plaque burden and relationship with adverse cardiovascular event in asymptomatic diabetic patients

  All patients (n = 197) Patients with CACS ≤10 (n = 156) Patients with CACS > 10 (n = 41)
Clinical characteristics
 Age, years (±SD) 63 ± 11.4 62.3 ± 11.3 66.1 ± 11.1
 Males 125 (63.4%) 96 (61.5%) 29 (70.7%)
 BMI, kg/m2 (±SD) 25.7 ± 3.3 25.8 ± 3.4 25.1 ± 3.1
 Hypercholesterolemia 85 (43%) 72 (46.1%) 13 (31.7%)
 Hypertension 113 (57.3%) 92 (58.9%) 21 (51.2%)
 Smoking 60 (30.4%) 48 (30.7%) 12 (29.3%)
 Family history of CAD 35 (17.8%) 26 (16.7%) 9 (21.9%)
 Baseline CAC Score 12.5 [0, 102.5] 6.5 [0, 9.8] 29.2 [11.3, 102.5]
Pretest likelihood of CAD
 Low 57 45 12
 Moderate 111 89 22
 High 29 22 7
Medical therapy
 Aspirin 110 (52.7%) 82 (52.5%) 22 (53.7%)
 Statins 71 (36.0%) 53 (34.0%) 18 (43.9%)
 Β-blocker 81 (41.1%) 57 (46.5%) 24 (58.5%)
 Calcium channel blocker 59 (29.9%) 46 (29.4%) 13 (31.7%)
CAD-RADS reporting data
 CAD-RADS 0 36 30 7
 CAD-RADS 1 51 41 13
 CAD-RADS 2 100 77 19
 CAD-RADS 3 10 8 2
  1. Values are shown as numbers with percentages in parentheses or mean values with standard deviation